Clearmind Medicine (Clearmind Medicine) Change In Receivables : $0.06 Mil (TTM As of Apr. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Clearmind Medicine Change In Receivables?

Clearmind Medicine's change in receivables for the quarter that ended in Apr. 2024 was $-0.02 Mil. It means Clearmind Medicine's Accounts Receivable increased by $0.02 Mil from Jan. 2024 to Apr. 2024 .

Clearmind Medicine's change in receivables for the fiscal year that ended in Oct. 2023 was $-0.11 Mil. It means Clearmind Medicine's Accounts Receivable increased by $0.11 Mil from Oct. 2022 to Oct. 2023 .

Clearmind Medicine's Accounts Receivable for the quarter that ended in Apr. 2024 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Clearmind Medicine's liquidation value for the three months ended in Apr. 2024 was $4.11 Mil.

Clearmind Medicine Change In Receivables Historical Data

The historical data trend for Clearmind Medicine's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clearmind Medicine Change In Receivables Chart

Clearmind Medicine Annual Data

Trend

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Change In Receivables

Get a 7-Day Free Trial

-0.09

0.02

-0.11

Clearmind Medicine Quarterly Data
	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24
Change In Receivables	Get a 7-Day Free Trial															0.10	-0.02	-	0.09	-0.02

Clearmind Medicine Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Apr. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.06 Mil.

Clearmind Medicine (NAS:CMND) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Clearmind Medicine's Days Sales Outstanding for the quarter that ended in Apr. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, Clearmind Medicine's accounts receivable are only considered to be worth 75% of book value:

Clearmind Medicine's liquidation value for the quarter that ended in Apr. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	8.306	-	4.2	+	0.75 * 0	+	0.5 * 0
=	4.11

Clearmind Medicine Change In Receivables Related Terms

Thank you for viewing the detailed overview of Clearmind Medicine's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Clearmind Medicine (Clearmind Medicine) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clearmind Medicine Inc (NAS:CMND) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

CWY0:Germany CWY0:Germany CMND:Canada

Address

101-1220 West 6th Avenue, Vancouver, BC, CAN, V6H 1A5

Website

https://www.clearmindmedicine.com

Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.